Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Grova, Mauro
42  Ergebnisse:
Personensuche X
?
1

Current Approaches for Monitoring of Patients with Inflamma..:

Vitello, Alessandro ; Maida, Marcello ; Shahini, Endrit...
Journal of Clinical Medicine.  13 (2024)  4 - p. 1008 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Safety and effectiveness of tofacitinib in ulcerative colit..:

Macaluso, Fabio Salvatore ; D'Antonio, Elvira ; Fries, Walter...
Digestive and Liver Disease.  56 (2024)  1 - p. 15-20 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Switching from SB2 to PF-06438179/GP1111 and back in inflam..:

Macaluso, Fabio Salvatore ; Casà, Angelo ; Renna, Sara...
Digestive and Liver Disease.  55 (2023)  3 - p. 424-425 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Sarcopenia is a negative predictive factor for endoscopic r..:

Grova, Mauro ; Crispino, Federica ; Maida, Marcello...
Digestive and Liver Disease.  55 (2023)  7 - p. 865-871 , 2023
Link: https://doi.org/10.1016/..
 
?
5

The effectiveness of ustekinumab and vedolizumab as third-l..:

Macaluso, Fabio Salvatore ; Grova, Mauro ; Saladino, Marica...
Digestive and Liver Disease.  55 (2023)  4 - p. 471-477 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Ustekinumab is a promising option for the treatment of post..:

Macaluso, Fabio Salvatore ; Grova, Mauro ; Mocciaro, Filippo...
Journal of Gastroenterology and Hepatology.  38 (2023)  9 - p. 1503-1509 , 2023
Link: https://doi.org/10.1111/..
 
?
7

Spondyloarthropathy in Inflammatory Bowel Disease: From Pat..:

Crispino, Federica ; Grova, Mauro ; Bruno, Erica Maria...
Drugs.  82 (2022)  11 - p. 1151-1163 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Effectiveness of adalimumab for ulcerative colitis: A multi..:

Vitello, Alessandro ; Grova, Mauro ; Pugliese, Daniela...
Digestive and Liver Disease.  54 (2022)  3 - p. 352-357 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Direct-acting antiviral agents and risk of Hepatocellular c..:

Celsa, Ciro ; Stornello, Caterina ; Giuffrida, Paolo...
Annals of Hepatology.  27 (2022)  - p. 100568 , 2022
Link: https://doi.org/10.1016/..
 
?
10

An Objective Comparison of Vedolizumab and Ustekinumab Effe..:

Onali, Sara ; Pugliese, Daniela ; Caprioli, Flavio Andrea...
American Journal of Gastroenterology.  117 (2022)  8 - p. 1279-1287 , 2022
Link: https://doi.org/10.14309..
 
?
11

Benign liver lesions 2022: Guideline for clinical practice ..:

Pompili, Maurizio ; Ardito, Francesco ; Brunetti, Enrico...
Digestive and Liver Disease.  54 (2022)  12 - p. 1614-1622 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Benign liver lesions 2022: Guideline for clinical practice ..:

Pompili, Maurizio ; Ardito, Francesco ; Brunetti, Enrico...
Digestive and Liver Disease.  54 (2022)  11 - p. 1469-1478 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Efficacy and safety of Atezolizumab plus Bevacizumab-based ..:

Celsa, Ciro ; Cabibbo, Giuseppe ; Battaglia, Salvatore...
Journal of Hepatology.  77 (2022)  - p. S387-S388 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Vedolizumab may be an effective option for the treatment of..:

Macaluso, Fabio Salvatore ; Cappello, Maria ; Crispino, Federica...
Digestive and Liver Disease.  54 (2022)  5 - p. 629-634 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Head-to-head comparison of biological drugs for inflammator..:

Macaluso, Fabio Salvatore ; Maida, Marcello ; Grova, Mauro...
Therapeutic Advances in Gastroenterology.  14 (2021)  - p. 175628482110106 , 2021
Link: https://doi.org/10.1177/..
 
1-15